SIGN UP LOGIN    
BIOSOLUTION CO.,LTD.
Country Korea, South
Tel +82-2-3446-8884
URL www.biosolutions.co.kr

EXHIBITION    KOREA LAB 2021

Booth No. 5C802
last updated on ( 2022-06-28 )

Our company was established with the purpose of developing, manufacturing and selling cell therapy products. We have developed a human tissue model and an alternative test method through the application of our proprietary cell therapy development technology, and attained international certification of the model (listed in the OECD TG on April 2019). We seek to not only to make our technology known, but also preemptively react to future market trends to ensure constant growth and development moving forward. Based on our advanced cell-based application technology and its wide application to numerous cells, we not only aim to research and manufacture products which address the limitations of pre-existing products, but also innovate and commercialize our products to ensure we maintain market relevancy and technological superiority.

more

EXHIBIT

Alternativemodel-SoluOral™(3D human oral epithelial model)

SoluOral consists of normal human oral epithelial cells which have been cultured to form a nonkeratinized oral epithelium. 1. Features ? Oral mucosa-like structure ? Non-keratinized stratified human oral epithelial cells ? p63 positive cells enriched basal layer ? Cost-effective alternative to animal and clinical testing 2. Application ? Irritation test of oral care product ? Biocompatibility of new dental materials ? Oral cavity pathology

More

Alternativemodel-SoluAirway™(3D human nasal mucosa epithelial model)

SoluAirwayTM consists of normal human nasal mucosa epithelial cells which have been cultured to form a pseudostratified, mucociliary epithelium. 1. Features ? Human nasal mucosa epithelial cell based mucosa model ? Human upper airway?like structure ? Mucin producing, ciliated structure ? Cost-effective alternative to animal and clinical testing 2. Application ? Inhalation toxicity test ? Organotypic nasal drug delivery test ? 3D Model of respiratory tract tissue

More

Alternativemodel-MCTT HCE™(3D human corneal epithelial model)

MCTT HCE system consists of normal human corneal epithelial cells which have been cultured to form multilayered human corneal epithelia. 1. Features ? Corneal epithelium-like structure ? Non-transformed, normal human corneal epithelial cell ? Multiple layers of viable epithelial cell (basal, transitional wing, superficial squamous) ? p63 positive cells enriched basal layer 2. Application ?Pre-clinical screening model for drug development ?Ocular irritation test

More

Alternativemodel-KeraSkin™(3D Skin model)

KeraSkin™ System consists of normal human epidermal keratinocytes which have been cultured to form a multilayered, highly differentiated human epidermis. 1. Features - Non-transformed, normal human keratinocyte - Multiple layers of viable epithelial cell (basal, stratum spinosum, stratum granulosum) 2. Application - In vitro skin corrosion/irritation (OECD TG 431/439 guidelines) - Phototoxicity test/Genotoxicity test - Efficacy test model for cosmetic ingredients

More

COMPANY INTRODUCTION

Our company was established with the purpose of developing, manufacturing and selling cell therapy products. We have developed a human tissue model and an alternative test method through the application of our proprietary cell therapy development technology, and attained international certification of the model (listed in the OECD TG on April 2019). We seek to not only to make our technology known, but also preemptively react to future market trends to ensure constant growth and development moving forward. Based on our advanced cell-based application technology and its wide application to numerous cells, we not only aim to research and manufacture products which address the limitations of pre-existing products, but also innovate and commercialize our products to ensure we maintain market relevancy and technological superiority.

QUICK LINK

Inquiry

Sender
/
Purpose *
Available Amount for a deal *
Details

SHARE

SHARE

REQUEST THE VIDEO MEETING

  • (KST, UTC+09:00)

    This above time is Korean local time.
    The time for meeting is based on Korean local time.
    Please check Korean time, and choose the time available.
Sender
/ JW pharma
Receiver
박영수 / BIOSOLUTION CO.,LTD.
Purpose *
Available Amount for a deal *
Date *
Time *
Attendee 1 *
Attendee 2
Massage